dc.contributor.author |
Qwebani-Ogunleye, Tozama
|
|
dc.contributor.author |
Kolesnikova, Natalia I
|
|
dc.contributor.author |
Steenkamp, Paul A
|
|
dc.contributor.author |
De Koning, CB
|
|
dc.contributor.author |
Brady, D
|
|
dc.contributor.author |
Wellington, Kevin W
|
|
dc.date.accessioned |
2017-09-04T12:39:54Z |
|
dc.date.available |
2017-09-04T12:39:54Z |
|
dc.date.issued |
2016-12 |
|
dc.identifier.citation |
Qwebani-Ogunleye , T., Kolesnikova, N.I., Steenkamp, P.A. et al. 2016. A one-pot laccase-catalysed synthesis of coumestan derivatives and their anticancer activity. Bioorganic & Medicinal Chemistry, vol. 25(3): 1172-1182. doi.org/10.1016/j.bmc.2016.12.025 |
en_US |
dc.identifier.issn |
0968-0896 |
|
dc.identifier.uri |
doi.org/10.1016/j.bmc.2016.12.025
|
|
dc.identifier.uri |
http://www.sciencedirect.com/science/article/pii/S0968089616311208
|
|
dc.identifier.uri |
http://hdl.handle.net/10204/9535
|
|
dc.description |
Copyright: 2016 Elsevier. Due to copyright restrictions, the attached PDF file only contains the abstract of the full text item. For access to the full text item, kindly consult the publisher's website. |
en_US |
dc.description.abstract |
Suberase®, a commercial laccase from Novozymes, was used to catalyse the synthesis of coumestans. The yields, in some cases, were similar to or better than that obtained by other enzymatic, chemical or electrochemical syntheses. The compounds were screened against renal TK10, melanoma UACC62 and breast MCF7 cancer cell-lines and the GI50, TGI and LC50 values determined. Anticancer screening showed that the cytostatic effects of the coumestans were most effective against the melanoma UACC62 and breast MCF7 cancer cell-lines exhibiting potent activities, GI50 = 5.35 and 7.96 µM respectively. Moderate activity was obtained against the renal TK10 cancer cell-line. The total growth inhibition, based on the TGI values, of several of the compounds was better than that of etoposide against the melanoma UACC62 and the breast MCF7 cancer cell lines. Several compounds, based on the LC50 values, were also more lethal than etoposide against the same cancer cell lines. The SAR for the coumestans is similar against the melanoma UACC62 and breast MCF7 cell lines. The compound having potent activity against both breast MCF7 and melanoma UACC62 cell lines has a methyl group on the benzene ring (ring A) as well as on the catechol ring (ring B). Anticancer activity decreases when methoxy and halogen substituents are inserted on rings A and B. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Elsevier |
en_US |
dc.relation.ispartofseries |
Worklist;18673 |
|
dc.subject |
Laccase |
en_US |
dc.subject |
Biocatalysis |
en_US |
dc.subject |
Coumestans |
en_US |
dc.subject |
Wedelolactone analogues |
en_US |
dc.subject |
Michael addition |
en_US |
dc.subject |
Renal cancer |
en_US |
dc.subject |
Melanoma cancer |
en_US |
dc.subject |
Breast cancer |
en_US |
dc.subject |
Anticancer activity |
en_US |
dc.title |
A one-pot laccase-catalysed synthesis of coumestan derivatives and their anticancer activity |
en_US |
dc.type |
Article |
en_US |
dc.identifier.apacitation |
Qwebani-Ogunleye, T., Kolesnikova, N. I., Steenkamp, P. A., De Koning, C., Brady, D., & Wellington, K. W. (2016). A one-pot laccase-catalysed synthesis of coumestan derivatives and their anticancer activity. http://hdl.handle.net/10204/9535 |
en_ZA |
dc.identifier.chicagocitation |
Qwebani-Ogunleye, Tozama, Natalia I Kolesnikova, Paul A Steenkamp, CB De Koning, D Brady, and Kevin W Wellington "A one-pot laccase-catalysed synthesis of coumestan derivatives and their anticancer activity." (2016) http://hdl.handle.net/10204/9535 |
en_ZA |
dc.identifier.vancouvercitation |
Qwebani-Ogunleye T, Kolesnikova NI, Steenkamp PA, De Koning C, Brady D, Wellington KW. A one-pot laccase-catalysed synthesis of coumestan derivatives and their anticancer activity. 2016; http://hdl.handle.net/10204/9535. |
en_ZA |
dc.identifier.ris |
TY - Article
AU - Qwebani-Ogunleye, Tozama
AU - Kolesnikova, Natalia I
AU - Steenkamp, Paul A
AU - De Koning, CB
AU - Brady, D
AU - Wellington, Kevin W
AB - Suberase®, a commercial laccase from Novozymes, was used to catalyse the synthesis of coumestans. The yields, in some cases, were similar to or better than that obtained by other enzymatic, chemical or electrochemical syntheses. The compounds were screened against renal TK10, melanoma UACC62 and breast MCF7 cancer cell-lines and the GI50, TGI and LC50 values determined. Anticancer screening showed that the cytostatic effects of the coumestans were most effective against the melanoma UACC62 and breast MCF7 cancer cell-lines exhibiting potent activities, GI50 = 5.35 and 7.96 µM respectively. Moderate activity was obtained against the renal TK10 cancer cell-line. The total growth inhibition, based on the TGI values, of several of the compounds was better than that of etoposide against the melanoma UACC62 and the breast MCF7 cancer cell lines. Several compounds, based on the LC50 values, were also more lethal than etoposide against the same cancer cell lines. The SAR for the coumestans is similar against the melanoma UACC62 and breast MCF7 cell lines. The compound having potent activity against both breast MCF7 and melanoma UACC62 cell lines has a methyl group on the benzene ring (ring A) as well as on the catechol ring (ring B). Anticancer activity decreases when methoxy and halogen substituents are inserted on rings A and B.
DA - 2016-12
DB - ResearchSpace
DP - CSIR
KW - Laccase
KW - Biocatalysis
KW - Coumestans
KW - Wedelolactone analogues
KW - Michael addition
KW - Renal cancer
KW - Melanoma cancer
KW - Breast cancer
KW - Anticancer activity
LK - https://researchspace.csir.co.za
PY - 2016
SM - 0968-0896
T1 - A one-pot laccase-catalysed synthesis of coumestan derivatives and their anticancer activity
TI - A one-pot laccase-catalysed synthesis of coumestan derivatives and their anticancer activity
UR - http://hdl.handle.net/10204/9535
ER -
|
en_ZA |